Advances in biocatalytic synthesis of pharmaceutical intermediates

Current Opinion in Chemical Biology

Volumn 9, Issue 2, 2005, Pages 188-194

  Panke, Sven ^a   Wubbolts, Marcel ^b  

^a ETH ZURICH   (Switzerland)

^b DSM RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEHYDRO 3 DEOXYPHOSPHOHEPTONATE ALDOLASE; 4 CHLORO 3 HYDROXYBUTANOATE; 4 CYANO 3 HYDROXYBUTANOIC ACID; AMINO ACID; ATORVASTATIN; BACTERIAL ENZYME; BENZOIC ACID DERIVATIVE; BUTYRIC ACID DERIVATIVE; CHYMOTRYPSIN A; EPHEDRINE; FRUCTOSE BISPHOSPHATE ALDOLASE; HEXANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; KETONE; OMAPATRILAT; OSELTAMIVIR; OXIDOREDUCTASE; PROTEINASE INHIBITOR; PYRUVATE DECARBOXYLASE; SHIKIMIC ACID; UNCLASSIFIED DRUG;

BIOCATALYST; BIOTECHNOLOGY; CATALYSIS; CHEMICAL REACTION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG SCREENING; ENANTIOSELECTIVITY; ENZYME SPECIFICITY; GENOMICS; HYDROLYSIS; REDUCTION; REVIEW; SYNTHESIS;

EID: 16244402638     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2005.02.007     Document Type: Review

References (27)

1. M. Breuer, K. Ditrich, T. Habicher, B. Hauer, M. Kesseler, R. Stürmer, and T. Zelinski Industrial methods for the production of optically active intermediates Angew Chem Int Ed Engl 43 2004 788 824 Comprehensive review on industrial manufacturing of chiral intermediates using classical resolution approaches, biocatalysis as well as chemical catalysis.
2. S. Panke, M. Held, and M.G. Wubbolts Trends and innovations in industrial biocatalysis for the production of fine chemicals Curr Opin Biotechnol 15 2004 272 279
3. N.M. Shaw, K.T. Robbins, and A. Kiener Biocatalytic approaches for the large-scale production of asymmetric synthons H.U. Blaser E.S. Schmidt Asymmetric Catalysis on Industrial Scale 2004 Wiley-VCH 105 115
4. D.R. Yasbeck Challenges in the development of an efficient enzymatic process in the pharmaceutical industry Tetrah Asymmetry 15 2004 2757 2763
5. R. Patel, R. Hanson, A. Goswami, V. Nanduri, A. Banerjee, M.-J. Donovan, S. Goldberg, R. Johnston, D. Brzozowski, and T. Tully Enzymatic synthesis of chiral intermediates for pharmaceuticals J Ind Microbiol Biotechnol 30 2003 252 259
6. M. Müller Chemoenzymatic synthesis of building blocks for statin side chains Angew Chem Int Ed Engl 44 2005 362 365 Excellent review on chemoenzymatic routes towards HMGCoA reductase inhibitors.
7. J.H. Lutje Spelberg, L. Tang, R.M. Kellogg, and D.B. Janssen Enzymatic dynamic kinetic resolution of epihalohydrins Tetrahedron Asymmetry 15 2004 1095 1102
8. Davis SC, Grate JH, Gray DR, Gruber JM, Huisman GW, Ma SK, Newman LM, Sheldon R, Wang LA: Halohydrin dehalogenases and method for production of 4-cyano-3-hydroxybutyric acid esters and amides. WO 2004/015132, (Codexis Inc.).
9. D.E. Robertson, J.A. Chaplin, G. DeSantis, M. Podar, M. Madden, E. Chi, T. Richardson, A. Milan, M. Miller, and D.P. Weiner Exploring nitrilase sequence space for enantioselective catalysis Appl Environ Microbiol 70 2004 2429 2436
10. G. Desantis, K. Wong, B. Farwell, K. Chatman, Z. Zhu, G. Tomlinson, H. Huang, X. Tan, L. Bibbs, and P. Chen Creation of a productive, highly enantioselective nitrilase through gene site saturation mutagenesis (GSSM) J Am Chem Soc 125 2003 11476 11477 Illustrating the power of directed evolution to adapt enzymes to conditions that are required in industrial processes (high selectivity, productivity and concentrations).
11. R. Öhrlein, and G. Baisch Chemo-enzymatic approach to statin side-chain building blocks Adv Synth Catal 345 2003 713 715 Deracemization with cheaply available enzymes to catalyze the synthesis of statin side chains.
12. Kierkels JGT, Mink D, Panke S, Lommen FAM, Heemskerk D: Process for the preparation of 2,4-dideoxyhexoses and therapeutic uses thereof. WO 2003/006656, (DSM).
13. W.A. Greenberg, A. Varvak, S.R. Hanson, K. Wong, H. Huang, P. Chen, and M.J. Burk Development of an efficient, scalable, aldolase catalyzed process for enantioselective synthesis of statin intermediates Proc Natl Acad Sci USA 101 2004 5788 5793
14. G. DeSantis, J. Liu, D.P. Clark, A. Heine, I.A. Wilson, and C.-H. Wong Structure-based mutagenesis approaches towards expanding the substrate specificity of D-2-deoxyribose-5-phosphate aldolase Bioorg Med Chem 11 2003 43 52 Use of high-resolution 3D structure information to construct mutants of an enzyme that can accommodate a new substrate. Potential new route to atorvastatin (see also [15]).
15. J. Liu, C.-C. Hsu, and C.-H. Wong Sequential aldol condensation catalyzed by DERA mutant Ser238Asp and a formal total synthesis of atorvastatin Tetrahedron Lett 45 2004 2439 2441
16. A.K. Mandwal, C.K.M. Tripathi, P.D. Trivedi, A.K. Joshi, S.C. Agarwal, and V. Bihari Production of L-phenylacetyl carbinol by immobilized cells of Saccharomyces cerevisiae Biotechnol Lett 26 2004 217 221
17. B. Rosche, V. Sandford, M. Breuer, B. Hauer, and P.L. Rogers Enhanced production of R-phenylacetylcarbinol (R-PAC) through enzymatic biotransformation J Mol Catal B Enzym 19-20 2002 109 115
18. B. Rosche, M. Breuer, B. Hauer, and P.L. Rogers Biphasic aqueous/organic biotransformation of acetaldehyde and benzaldehyde by Zymomonas mobilis pyruvate decarboxylase Biotechnol Bioeng 86 2004 788 794 Excellent example of how even a well-established process can be improved by a change of enzyme system and process development.
19. B. Zelic, S. Gostovic, K. Vuorilehto, D. Vasic-Racki, and R. Takors Process strategies to enhance pyruvate production with recombinant Escherichia coli: from repetitive fed-batch to in situ product recovery with fully integrated electrodialysis Biotechnol Bioeng 85 2004 638 646
20. T.B. Causey, K.T. Shanmugam, L.P. Yomano, and L.O. Ingram Engineering Escherichia coli for efficent conversion of glucose to pyruvate Proc Natl Acad Sci USA 101 2004 2235 2240
21. M. Breuer, M. Pohl, B. Hauer, and B. Lingen High-throughput assay of (R)-phenylacetylcarbinol synthesized by pyruvate decarboxylase Anal Bioanal Chem 374 2002 1069 1073
22. M. Krämer, J. Bongaerts, R. Bovenberg, S. Kremer, U. Müller, S. Orf, M. Wubbolts, and L. Raeven Metabolic engineering for microbial production of shikimic acid Metab Eng 5 2003 277 283
23. J. Guo, and J.W. Frost Synthesis of aminoshikimic acid Org Lett 6 2004 1585 1588 From solving the enigma on the biosynthesis of aminoshikimic acid as present in natural products towards a means to produce the molecule.
24. N. Ran, K. Draths, and J.W. Frost Creation of a shikimate pathway variant J Am Chem Soc 126 2004 6856 6857 First example of engineering a new link between central carbon metabolism and the shikimic pathway, aimed at solving limitations in PEP flux due to the PTS sugar transport system.
25. D. Franke, V. Lorbach, S. Esser, C. Dose, G.A. Sprenger, M. Halfar, J. Thömmes, R. Müller, R. Takors, and M. Müller (S,S)-2,3-dihydroxy- 2,3-dihydrobenzoic acid: microbial access with engineered cells of Escherichia coli and application as starting material in natural product synthesis Chem Eur J 9 2003 4188 4196
26. D. Franke, G.A. Sprenger, and M. Müller Easy access to (R,R)-3,4-dihydroxy-3,4-dihydrobenzoic acid with engineered strains of Escherichia coli ChemBioChem 4 2003 775 777
27. T.H.P. Maier Semisynthetic production of unnatural L-α-amino acids by metabolic engineering of the cysteine-biosynthetic pathway Nat Biotechnol 21 2003 422 427 Both by metabolically engineering the cysteine pathway of E. coli and by feeding precursors to the fermentation process, new routes to intermediates of potential pharmaceutical interest were obtained.